Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CARTO™ 3 EP Navigation System V8.1

K-Number: K252302 · 2025-08-22

Decision Date2025-08-22
Product CodeDQK
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

CARTO™ 3 EP Navigation System V8.1 is a medical device manufactured by Biosense Webster, Inc.. It received FDA 510(k) clearance on 2025-08-22 under approval number K252302. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CARTO™ 3 EP Navigation System V8.1?

CARTO™ 3 EP Navigation System V8.1 is a medical device that received FDA 510(k) clearance on 2025-08-22. It is manufactured by Biosense Webster, Inc.. The 510(k) number is K252302.

When was CARTO™ 3 EP Navigation System V8.1 approved by the FDA?

CARTO™ 3 EP Navigation System V8.1 received FDA 510(k) clearance on 2025-08-22, under approval number K252302.

What company makes CARTO™ 3 EP Navigation System V8.1?

CARTO™ 3 EP Navigation System V8.1 is manufactured by Biosense Webster, Inc..

What is the FDA product code for CARTO™ 3 EP Navigation System V8.1?

The FDA product code for CARTO™ 3 EP Navigation System V8.1 is DQK.

Related Clinical Trials

Related PubMed Literature

Other Devices by Biosense Webster, Inc.

View all 33 devices →

Related Devices (Code: DQK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.